ESMO 2016 conference highlights

Bookmark and Share
Published: 12 Oct 2016
Views: 5582
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ecancer blogger Dr Gyawali gives his scientific highlights from ESMO 2016, covering the likely impact of the research.

For more on niraparib in platinum-resistant ovarian cancer, ecancer spoke with Dr Mansoor Raza Mirza here.

For more on adjuvant ipilumumab for melanoma, ecancer spoke with Dr Alexander Eggermont here.

For more on ribociclib for breast cancer, ecancer spoke with Dr Gabriel Hortobagyi here.

For more on KEYNOTE-024 trial of pembrolizumab for NSCLC, ecancer spoke with Dr Martin Reck here.

For more on nivolumab for head and neck, you can read more through ecancer news.

For more on adjuvant sunitinib ecancer spoke with Dr Alian Ravaud here.

For more from Dr Gyawali, read his regular blog with ecancer here.

ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.